Skip to main content
Explore our network
All sites

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation News.

📰 Related Stories

📰 General

Trump admin insists recent closely timed tech outages aren't connected

CNBC17m ago
📰 General

Consumers fret about inflation as execs fixate on interest rates - CFO.com

Google News23m ago
Pebblebee Alert Dispatch lets an actual human respond to your emergency, triggered by Find Hub trackers
📰 General

Pebblebee Alert Dispatch lets an actual human respond to your emergency, triggered by Find Hub trackers

9to5Google34m ago
📰 General

Jim Cramer's top 10 things to watch in the stock market Wednesday

CNBC38m ago
📰 General

How inflation is measured: 12 terms that explain the number behind the headline - qz.com

Google News40m ago
AAWireless releases new, smaller Nexus and Nano wireless Android Auto adapters
📰 General

AAWireless releases new, smaller Nexus and Nano wireless Android Auto adapters

9to5Google44m ago
← Back to News